News on China's scientific and technological development.

broadsword

Brigadier
December 2, 2024

Waste oil to wonder material: Transforming trash into supercapacitor gold​

by
Please, Log in or Register to view URLs content!


Waste oil to wonder material: Transforming trash into supercapacitor gold
Template-Free Fabrication of Nitrogen-Doped Hierarchical Porous Carbons from Waste Oil. The schematic illustrates the transformation process from linoleic acid and melamine into nitrogen-doped HPCs using CAPET carbonization and subsequent KOH activation. SEM images highlight the structural evolution, while elemental mapping confirms uniform nitrogen and oxygen distribution. The table shows the increase in specific surface area and mesopore volume after activation. The graph demonstrates the enhanced specific capacitance of N-doped HPCs, with LA-HPCs-N0.5 achieving a peak capacitance of 430.2 F g−1 at A g−1. Credit: Waste Disposal & Sustainable Energy (2024). DOI: 10.1007/s42768-024-00210-5

Amid an escalating global energy crisis, the need for high-performance energy storage solutions is more pressing than ever. Supercapacitors, known for their fast charge/discharge rates and longer cycle life compared to traditional batteries, have emerged as a critical component in future energy systems.
However, to meet growing demand, supercapacitors require high-quality electrode materials that balance conductivity with expansive surface area—an area where many conventional materials fall short. These challenges have spurred scientists to explore advanced carbon materials with intricate porous structures and strategically placed
Please, Log in or Register to view URLs content!
, a process known as heteroatom doping.
In a
Please, Log in or Register to view URLs content!
published in Waste Disposal & Sustainable Energy on October 18, 2024, researchers from the University of Shanghai for Science and Technology and Tongji University, introduced an innovative method to fabricate nitrogen-doped hierarchical porous carbons (HPCs) from waste oil.

Their approach, which utilizes carbonization under autogenic pressure at elevated temperatures (CAPET) and
Please, Log in or Register to view URLs content!
(KOH) activation, demonstrated substantial improvements in surface area, porosity, and energy
Please, Log in or Register to view URLs content!
performance. This process transforms waste oil into a high-value material with properties tailored for supercapacitor electrodes, offering a promising and sustainable solution for the energy storage industry.

The research team selected
Please, Log in or Register to view URLs content!
(found in waste oils) and melamine as carbon and nitrogen sources, respectively. After heating the materials to 600°C and treating them with KOH, the researchers produced HPCs with an impressive surface area of up to 3474.1 m2/g.

These HPCs featured mesopores, accounting for 72.9% to 77.3% of the total pore volume—essential for enhancing the material's storage capacity and ion transport efficiency. Nitrogen doping, facilitated by melamine, improved conductivity and introduced
Please, Log in or Register to view URLs content!
within the carbon framework, boosting electrochemical reactivity.

As a result, the HPCs achieved a specific capacitance of 430.2 F g−1, with a retention rate of 86.5% after 2,000 charge/discharge cycles.
"By using waste oil as a precursor, we're not only recycling waste into a valuable resource but also creating a supercapacitor material with exceptional electrochemical properties," said Dr. Suyun Xu, a leading researcher on the project.

"Our approach optimizes the pore structure and uses nitrogen doping to elevate the performance of supercapacitors, opening up new possibilities for sustainable, high-efficiency energy storage."

This study's potential applications extend beyond the laboratory, offering opportunities for energy technologies in a circular economy. By repurposing waste oil into a high-performing carbon material, this method reduces environmental waste while supporting eco-friendly and economical energy storage solutions.

The HPCs' improved performance in supercapacitors makes them suitable for use in
Please, Log in or Register to view URLs content!
, renewable energy storage, and other advanced applications, paving the way for greener, more efficient energy systems worldwide.


As the energy landscape evolves, innovations like this provide a promising glimpse into a future where waste materials are transformed into resources, ensuring that sustainability and high-performance technology can coexist.
 

canonicalsadhu

Junior Member
Registered Member
Please, Log in or Register to view URLs content!
Every major drugmaker’s head of R&D has been to China at least once in the last year, according to an October report from Stifel Financial’s investment banking unit. AbbVie and Bristol-Myers Squibb have hosted dedicated partnering days in Shanghai to meet with local companies, while companies such as Roche Holding, Bayer and Eli Lilly have opened or will open incubators to build relationships with early-stage startups. At a recent, widely watched trade expo, Pfizer announced it will invest US$1 billion in China over the next five years, in part to work with local companies.
“I have never seen so many multinationals coming to China searching,” said Darren Ji, the former head of Roche’s partnering activities in Asia and emerging markets. He added that the Shanghai biotech he co-founded and leads, Elpiscience Biopharmaceuticals, has entertained several multinationals.
Now, it is becoming a key hunting ground for truly novel therapies, in part thanks to a government initiative that has thrown support behind several cutting-edge industries. China has tripled its contributions to global asset licensing activities over the last six years, growing to 12 per cent of overall deals in 2023-24, McKinsey & Co wrote in a recent report.
 

interestedseal

Junior Member
Registered Member
Please, Log in or Register to view URLs content!
Please, Log in or Register to view URLs content!

Please, Log in or Register to view URLs content!

Please, Log in or Register to view URLs content!

Please, Log in or Register to view URLs content!

Please, Log in or Register to view URLs content!

License-out deals where Chinese biotech license their drug candidates out to big pharmas (usually for only ex-China rights) totaled 48 billion dollars from Q1-Q3 this year. Particularly these startups dominate the global ADC pipelines, an emerging form of molecules that combine antibodies with a drug with a linker. Note many of these candidates won’t be approved to become drugs (which is normal in this industry), so they are paid in terms of milestones
 

SanWenYu

Captain
Registered Member
The ZVS101e medicine injection, a genetic therapy for treating BCD (Bietti's Crystalline Dystrophy) developed by PKU recently started the stage 3 of clinical trials. This is the first BCD treatment in the world reaching this critical milestone. It is an original invention of PKU. Scientists spent more a decade in researching and developing this treatment.

BCD is caused by defective genes, a major contribution to irreversible total blindness in working age population. There has not been any proven treatment so far. Patients can become blind at the age of 40. It is estimated that there are between 60,000 to 140,000 BCD patients in China alone.

Please, Log in or Register to view URLs content!

近日,北京大学第三医院眼科杨丽萍课题组的研究成果(ZVS101e注射液)Ⅲ期临床试验方案获得国家药品监督管理局药品审评中心(CDE)同意,这是结晶样视网膜变性治疗领域全球范围内首个III期临床试验许可。

作为新药开发到上市过程中最为关键的里程碑事件,这标志着ZVS101e注射液正式进入关键性III期临床试验阶段。该转化成果关键III期临床试验的启动,标志着北京大学第三医院眼科在推进产学研深度融合的实践道路上迈出坚实的一步。

结晶样视网膜变性(BCD)是一种特殊类型的视网膜色素变性,典型改变为黄白色闪光结晶样物质沉积于视网膜,临床表现为夜盲、进行性视力下降和视野缩窄,患者通常40岁左右失明,目前无任何有效疗法。我国有BCD患者约6-14万,是工作年龄人群不可逆双眼盲的重要病因之一。BCD由CYP4V2基因突变所致,呈常隐遗传,基因突变导致其编码蛋白功能缺失,适合基因替代治疗。ZVS101e是含人CYP4V2基因的重组AAV载体。ZVS101e注射液视网膜下给药后,可高效感染视网膜细胞,并在细胞中特异性表达CYP4V2蛋白,弥补由于基因突变导致的蛋白功能缺失,从而对BCD患者的视网膜功能起到有效治疗作用。该基因替代治疗产品将适用于所有携带CYP4V2基因突变的BCD患者。
ZVS101e注射液是北京大学第三医院眼科杨丽萍课题组历时10余年研究开发的具有独立自主知识产权“从零到一”的原始创新药。2021年3月完成知识产权转让。2021年8月获得美国FDA孤儿药资格认证。2022年12月分别获得中国和美国I/II期临床试验许可,是世界范围内首个进入临床试验的BCD基因治疗产品。

截至目前,ZVS101e已经完成三项临床试验,是针对BCD疾病进行的样本量最大、观察时间最长,最系统的临床研究。研究结果显示ZVS101e具有良好的安全性和有效性,部分临床试验结果已发表于Signal Transduction and Targeted Therapy(IF:39.3)。该产品因在三项临床试验中展现的优异的有效性和安全性数据,分别于2024年6月被中国药品审评中心(CDE)纳入突破性治疗药物名单,2024年7月被美国FDA认定为再生医学先进疗法(RMAT),是国内第一个被FDA授予此荣誉的基因治疗产品。
 

SanWenYu

Captain
Registered Member
Using AI, scientists from a CAS facility in Xinjiang made a breakthrough in determining viscosity of melted basalt with high accuracy. This results in more precise control of thickness and strength of basalt fibres. The max tensile strength of the fibres made from local basalt ores is measured as high as 2061MPa, strong enough for making wind turbine blades. A production line is currently under construction for the goal of annual output of 20000 tons of basalt fibres.

Please, Log in or Register to view URLs content!

玄武岩纤维是以天然玄武岩矿石为原料,经高温熔融拉制而成的纤维材料。玄武岩熔体的粘度对于控制矿石熔融过程、明确熔体成纤温度、降低纤维生产成本十分重要。通常采用高温粘度计来测定玄武岩熔体的粘度,但面临着测试步骤复杂、耗时长等不足。此外,作为一种天然矿物,玄武岩矿石中含有多种氧化物且组分含量波动较大,这给准确表征矿石的熔融特性带来一定挑战。

近期,中国科学院新疆理化技术研究所科研团队与香港理工大学合作,在玄武岩矿石熔体粘度预测方面取得进展。基于课题组前期的测试结果和公开报道的文献数据,科研人员构建了涵盖玄武岩氧化物含量、温度和熔体粘度等特征的数据集合(包括70种玄武岩矿石组成和2849条温度-粘度数据),运用数据驱动的人工智能技术,采用随机森林(RF)和梯度提升决策树(GBDT)两种机器学习模型,实现了对玄武岩矿石熔体粘度的准确预测。其中,GBDT模型在整个数据集上表现更为出色,相对误差仅为0.04%,决定系数(用于反映回归模式可靠程度的统计指标)高达0.99。通过对模型进行解释性分析,科研人员发现玄武岩矿石中硅、铁、镁等金属氧化物组成对粘度的影响尤为显著(图1A),这主要是因为上述氧化物在玄武岩熔体网络结构中扮演着网络形成体的角色,进而影响熔体的流动特性。
基于建立的粘度-温度关系,科研人员成功预测了玄武岩熔体成纤的关键温度参数,如熔点、最低和最高成纤温度等。与实际测试数据相比,上述参数的预测误差均在2%以内(图1B)。在该结果的指导下,科研人员以东天山山脉的多种玄武岩矿石为原料,成功拉制出直径和强度可控的玄武岩纤维(图1B中内嵌图),其中单丝拉伸强度最高可达2061MPa,可作为增强材料用于制备风机叶片、光伏支架等。该项研究为高性能玄武岩纤维的熔融成纤工艺提供了理论依据,也为玄武岩资源的深度开发和应用提供了技术支撑。目前科研团队与新疆当地企业合作,正在建设年产2万吨玄武岩纤维生产线。

上述研究工作近期发表在《非晶固体》杂志上,研究工作得到新疆“天池英才”、“天山英才”培养计划和中国科学院“西部之光”等项目支持。
 
Top